Table 1.
Demographic and Clinical Characteristics of Study Participants (n=21).
| Characteristic | Number (%) |
|---|---|
| Sex (% male) | 10 (47.6) |
| History of suicide attempt | 3 (14.3) |
| Suicidal ideation present | 14 (66.7) |
| Prior exposure to anti-depressants | 11 (52.4) |
| Prior substance use disorder (alcohol or cannabis) | 3 (14.3) |
| Comorbid anxiety disorder | 10 (47.6) |
| Comorbid dysthymic disorder | 3 (14.3) |
| Ethnicity (%Hispanic) | 7 (33.3) |
| Race: | |
| Asian | 1 ( 4.8) |
| American Indian or Alaskan Native | 1 ( 4.8) |
| Black or African American | 4 (19.0) |
| White | 13 (61.9) |
| More than one race | 2 ( 9.5) |
| Mean ± SD | |
| Age (yrs) | 36.1 ± 11.9 |
| BMI (kg*m−2) | 26.6 ± 7.0 |
| Education (yrs) | 15.3 ± 2.7 |
| Income (US $1000/yr) | 31.1 ± 26.1 |
| Illness duration (yrs) | 14.6 ± 13.8 |
| Number of depressive episodes | 16.4 ± 35.9 |
| Age of onset (yrs) | 21.7 ± 9.0 |
| Length of current episode (wks) | 125.2 ±236.4 |
| HDRS-17 | 19.0 ± 4.6 |
| Plasma PUFAs (μg/ml) | |
| Docosahexaenoic acid (DHA) | 51.5 ± 31.3 |
| Eicosapentaenoic acid (EPA) | 21.9 ± 22.1 |
| Arachidonic acid (AA) | 234.5 ± 36.9 |
Abbreviations: BMI, body-mass index; HDRS-17, 17-item Hamilton Depression Rating Scale; PUFA, polyunsaturated fatty acids.